“…Although there are reports of PNGD or IGD occurrence following biological anti‐rheumatoid arthritis (RA) therapy, these anti‐rheumatoid therapeutic agents are used for PNGD or IGD treatment 5–9 . Here, we report a case of PNGD of the head that developed as a paradoxical adverse reaction following the administration of tocilizumab, an interleukin‐6 (IL‐6) inhibitor.…”